Stefanie Dimmeler, Institute for Cardiovascular Regeneration, Goethe-University Frankfurt am Main, Germany
Stefanie Dimmeler is born at the 18.07.1967 in Ravensburg, Germany. Dr. Dimmeler received her under-graduate, graduate, and Ph.D. degree from the University of Konstanz in Konstanz (Germany). She then completed a fellowship in Experimental Surgery at the University of Cologne and in Molecular Cardiology at the University of Frankfurt. She is Professor of Experimental Medicine (since 2001) and Director of the In-stitute of Cardiovascular Regeneration, Center for Molecular Medicine at the University of Frankfurt (Ger-many) since 2008.
She is author of more than 200 peer-reviewed papers, all of which published in highly qualified journals, including: "Nature", "Nature Medicine” “Nature Cell Biology”, "Journal of Experimental Medicine", "Journal of Clinical Investigations", “The New England Journal of Medicine”, "Circulation”, “Circulation Research”, and "Blood". Her global impact factor (IF) is higher than 1000 and her h-index is 82. In the last years, she has been invited as a speaker in more than 200 national and international meetings and seminars. She received several awards including the Award of the German Heart Foundation in 1998, the Frankel-Preis of the Ger-man Cardiac Society in 2000, the prestigious Alfried Krupp Award 2002 (500.000 €), the Leibniz Award 2005 (1.5 Mio €), the Award of the Jung Foundation 2007 and the FEBS award 2006. She presented the prestigious George E. Brown Memorial Lecture at the Scientific Sessions of the AHA in 2005 and the Basic Science Lecture of the European Society of Cardiology in 2006. She is presently on the editorial board of The Journal of Clinical Investigation, Circulation, Basic Research in Cardiology, and she is associated editor of the Circulation Research and European Heart Journal. She is co-director of the Transatlantic Network of Cardiac Regeneration supported by the Leducq Foundation and member of the Steering Committee of the “Excellence Cluster Cardio-Pulmonary System” (ECCPS), a translational research center in the field of vas-cular and parenchymal heart and lung diseases, funded by the DFG (Deutsche Forschungsgemeinschaft). Recently she received an Advanced grant by the European Research Community (ERC).
Her research is predominantly focused on endothelial cell biology, including signal transduction apoptosis, and renewal by circulation endothelial progenitor cells in health and disease. She identified novel signalling pathways mediating the synthesis and release of the endothelial protective factors NO. Together with Dr. Zeiher, she is responsible for the scientific discoveries culminating in current clinical trials of human progen-itor cells for cardiovascular repair.
« Go Back